Epilepsy
About Epilepsy — Neurological.
Neurological disorder characterised by recurrent seizures. Some cannabinoids have established anti-seizure efficacy for specific syndromes.
Tried something for Epilepsy? Share how it went — only ever published as part of a group of 10+.
No community reports published yet.
We publish epilepsy results only once at least 10 people report on the same compound, so no individual report is ever shown.
Used something for epilepsy? Share how it went — only ever published in a group of 10 or more.
Add your outcomePeer-reviewed research.
Strongest evidence first.
01Cannabidiol Use in Developmental and Epileptic Encephalopathies: A Syndrome- and Age-Stratified Systematic Review and Meta-analysisde Oliveira HM, et al. · CNS drugs · 2026Systematic Review · matched via Epilepsy · PubMed record (CORPUS-A)
PMID 42185726 ↗02Aplicaciones terapéuticas por acción de los cannabinoidesPlancarte-Sánchez R, et al. · Gaceta medica de Mexico · 2019Systematic Review · matched via Epilepsy · PubMed record (CORPUS-A)
PMID 31219471 ↗03Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru(®), vs an Oil-Based Formulation, Epidyolex(®), Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I StudyBendik I, et al. · CNS drugs · 2026Randomized Controlled Trial · matched via Epilepsy · open-access full text · PubMed record (CORPUS-A)
PMID 41888503 ↗04Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsyBirnbaum AK, et al. · Epilepsia · 2019Randomized Controlled Trial · matched via Epilepsy · PubMed record (CORPUS-A)
PMID 31247132 ↗05Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokersBabalonis S, et al. · Drug and alcohol dependence · 2017Randomized Controlled Trial · matched via Epilepsy · PubMed record (CORPUS-A)
PMID 28088032 ↗06Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndromeThiele EA et al. · N Engl J Med · 2017CBD at 20 mg/kg/day significantly reduced drop seizure frequency in Lennox-Gastaut syndrome versus placebo.
PMID 28578495 ↗Linked compounds.
Position is not a recommendation. Scores summarise published studies only.